Werewolf Therapeutics, Inc. (HOWL) vs Incannex Healthcare Limited (IXHL)
A side-by-side comparison of Werewolf Therapeutics, Inc. and Incannex Healthcare Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HOWL
Werewolf Therapeutics, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
IXHL
Incannex Healthcare Limited
$3.21HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — HOWL vs IXHL
growth of $100 · dividends reinvested · last 5yHOWL -84.6% (-31.2%/yr)IXHL -99.8% (-71.8%/yr)HOWL compounded faster over this window
Log scale — wide-divergence pair
HOWL IXHL
HOWL vs IXHL: by the numbers
- •HOWL is the larger company ($45M vs $38M market cap).
- •Both run net losses; IXHL's is the smaller (0.00% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | HOWL | IXHL |
|---|---|---|
| P/S ratio | 2.15 | N/A |
| P/B ratio | 2.77 | 0.57 |
Profitability
| Metric | HOWL | IXHL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -164.82% | 0.00% |
| ROE | -212.45% | -28.65% |
| ROIC | -156.97% | -32.18% |
Growth (annualized)
| Metric | HOWL | IXHL |
|---|---|---|
| Total return CAGR (5Y) | -44.27% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.